Filing Details
- Accession Number:
- 0001181431-11-011474
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-18 15:49:09
- Reporting Period:
- 2011-02-16
- Filing Date:
- 2011-02-18
- Accepted Time:
- 2011-02-18 15:49:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
820096 | Perrigo Co | PRGO | Pharmaceutical Preparations (2834) | 382799573 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1321178 | Moshe Arkin | C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-02-16 | 182,924 | $74.68 | 6,538,300 | No | 4 | S | Indirect | By Nichsei Arkin Ltd. |
Common Stock | Disposition | 2011-02-16 | 13,307 | $75.78 | 6,524,993 | No | 4 | S | Indirect | By Nichsei Arkin Ltd. |
Common Stock | Disposition | 2011-02-16 | 3,769 | $76.52 | 6,521,224 | No | 4 | S | Indirect | By Nichsei Arkin Ltd. |
Common Stock | Disposition | 2011-02-17 | 26,510 | $75.16 | 62,271 | No | 4 | S | Direct | |
Common Stock | Disposition | 2011-02-17 | 58,841 | $76.22 | 3,430 | No | 4 | S | Direct | |
Common Stock | Disposition | 2011-02-17 | 2,300 | $76.75 | 1,130 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By Nichsei Arkin Ltd. |
No | 4 | S | Indirect | By Nichsei Arkin Ltd. |
No | 4 | S | Indirect | By Nichsei Arkin Ltd. |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The price in column 4 is a weighted average. The prices actually received ranged from $74.34 to $75.31. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range
- The price in column 4 is a weighted average. The prices actually received ranged from $75.374 to $76.32. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range
- The price in column 4 is a weighted average. The prices actually received ranged from $75.42 to $76.58. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range
- The price in column 4 is a weighted average. The prices actually received ranged from $74.636 to $75.635. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range
- The price in column 4 is a weighted average. The prices actually received ranged from $75.64 to $76.64. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range
- The price in column 4 is a weighted average. The prices actually received ranged from $76.65 to $76.85. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range